Homeostasis Changes of Tear-Producing System with the Background of Cosmetic Procedures in Periorbital Area

Modern ophthalmological practice is inseverable linked with cosmetology and esthetic medicine. Every year, the number of patients, especially women, who received various types of cosmetology procedures (botulinum toxin injections, eyelash extensions, eyelid tattooing, dermal fillers injections, etc.) in facial area increases, in particular in the periorbital zone. Purpose: to conduct a comprehensive assessment of clinical and functional parameters characterizing the state of the ocular surface and the tear-producing system in case applying cosmetic procedures in the periorbital area (Botox injections, eyelid tattooing, eyelash extension). Patients and methods. The study included 106 women (212 eyes). Exclusion criteria: early postoperative period after ophthalmosurgical intervention, acute inflammatory diseases of anterior and posterior eye segment, glaucoma, the presence of intraocular pathological changes (hemophthalmia, detachment of the eye membranes, tumors). The average age of the patients included in the study was 36.37 ± 9.0 years. Results and discussion. The results of a comparative evaluation of two groups of patients — a group with a history of cosmetic procedures (tattooing the eyelids, botulinum toxin, dermal fillers, eyelash extensions) in the periorbital zone and patients who did not use such procedures, has showed that cosmetic procedures affect on the clinical and functional eye surfaces state and on morphofunctional state of meibomian glands. Thus, the frequency of detection of symptomocomplex of dry eye syndrome was on 36 % more often determined in the group of patients received cosmetic procedures. It has been shown that the combined effect of cosmetological procedures (tattooing the eyelids, eyelash extensions, injections of dermal fillers and botulinum toxin in the periorbital region) aggravates the course and prognosis of Dry Eye Syndrome and meibomian glands dysfunction. A direct correlation between the severity of complaints characteristic of Dry Eye Syndrome and the number of procedures was found (r = 0.4982, p = 0.0000); the frequency of detecting complaints of dryness and discomfort and the number of procedures (r = 0.6427, p = 0.0000); compression test indices and the number of procedures (r = –0.4712, p = 0.0000); the frequency of occurrence of inflammatory reactions of ocular surface and the number of procedures (r = 0.3778, p = 0.0001). The risk of tear production disturbance — dry eye syndrome and dysfunction of the meibomian glands is higher in patients using botulinum toxin injections and eyelash extension in comparison with patients using eyelid tattooing and injections of fillers with hyaluronic acid in the periorbital zone. 

1. Gomes J.A.P., Azar D.T., Baudouin C., Efron N., Hirayama M., Horwath-Winter J., Kim T., Mehta J.S., Messmer E.M., Pepose J.S., Sangwan V.S., Weiner A.L., Wilson S.E., Wolffsohn J.S. TFOS DEWS II iatrogenic report. Ocul Surf. 2017 Jul;15(3):511–538. DOI: 10.1016/j.jtos.2017.05.004. Epub 201

2. Kojima T., Dogru M., Matsumoto Y., Goto E., Tsubota K. Tear film and ocular surface abnormalities after eyelid tattooing. Ophthal Plast Reconstr Surg. 2005 Jan;21(1):69–71.

3. Trubilin V.N., Poluninа E.G., Andzhelova D.V., Kurenkov V.V., Kapkova S.G., Chinenova K.V. Effect of cosmetic procedures in the periorbital area on the organ of vision. Overview. Ophthalmology in Russia. 2018;15(3):233–241. DOI: 10.18008/1816-5095-2018-3-233-241

4. Amano Y., Nishiwaki Y. National survey on eyelash extensions and their related health problems. Nihon Eiseigaku Zasshi. 2013;68(3):168–174.

5. Abah E.R., Oladigbolu K.K., Rafindadi ALRafindadi A.L., Audu O. Eyelash extension use among female students in a Tertiary Institution in Nigeria: A study of kaduna polytechnic, Kaduna. Niger J Clin Pract. 2017 Dec;20(12):1639–1643. DOI: 10.4103/njcp.njcp_124_17

6. Ullrich K., Saha N. Semipermanent eyelash extensions causing bacterial keratitis: a case report. Semipermanent eyelash extensions causing bacterial keratitis: a case report. Can J Ophthalmol. 2013 Jun;48(3):e50-1. DOI: 10.1016/j.jcjo.2012.12.010

7. Michaels J.P., Macdonald P. Ignition of eyelash extensions during routine minor eyelid surgery. Ophthalmic Plast Reconstr Surg. 2014 May-Jun;30(3):e61-2. DOI: 10.1097/IOP.0b013e31829bb476

8. Dowlut M.S., Ahmed Y., Knox A. Ocular Inflammation Associated With Fibers From Eyelash Extensions. JAMA Ophthalmol. 2018 Jan 11;136(1):e175723. DOI: 10.1001/jamaophthalmol.2017.5723. Epub 2018 Jan 11.

9. Lindström I., Suojalehto H., Henriks-Eckerman M.L., Suuronen K. Occupational asthma and rhinitis caused by cyanoacrylate-based eyelash extension glues. Occup Med (Lond). 2013 Jun;63(4):294–297. DOI: 10.1093/occmed/kqt020

10. Lee Y.B., Kim J.J., Hyon J.Y., Wee W.R., Shin Y.J. Eyelid Tattooing Induces Meibomian Gland Loss and Tear Film Instability. Cornea. 2015 Jul;34(7):750–755. DOI: 10.1097/ICO.0000000000000452

11. Bo Ram Seol, Ji Won Kwon, Won Ryang Wee, Young Keun Han. A Case of Meibomian Gland Dysfunction after Cosmetic Eyelid Tattooing Procedure. Korean Ophthalmol Soc. 2013 Aug;54(8):1309–1313. Korean Published online August 14, 2013. DOI: 10.3341/jkos.2013.54.8.1309

12. Beleznay K., Humphrey S., Carruthers J.D., Carruthers A. Vascular compromise from soft tissue augmentation: Experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol. 2014;7:37–43.

13. Beleznay K., Carruthers J.D., Humphrey S., Jones D. Avoiding and treating blindness from fillers: A review of the world literature. Dermatol Surg. 2015;41:1097–1117.

14. Hwang J.C. Periorbital Injectables: Understanding and Avoiding Complications. J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):73–79. DOI: 10.4103/0974-2077.184049

15. Xiu Zhuo Hu, Jun Yan Hu, Peng Sen Wu, Sheng Bo Yu, Don O. Kikkawa, Wei Lu. Posterior Ciliary Artery Occlusion Caused by Hyaluronic Acid Injections into the Forehead. Medicine (Baltimore). 2016 Mar;95(11):e3124. Published online 2016 Mar 18. DOI: 10.1097/MD.0000000000003124

16. Carruthers J. et al. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 1995;32(5):306–308. Review.

17. Emel Başar, Ceyhun Arıcı. Use of Botulinum Neurotoxin in Ophthalmology. Turk J Ophthalmol. 2016 Dec;46(6):282–290. Published online 2016 Dec 1. DOI: 10.4274/tjo.57701

18. Coté T.R., Mohan A.K., Polder J.A., Walton M.K., Braun M.M. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005 Sep;53(3):407–415.

19. Evidente V.G., Truong D., Jankovic J., Comella C.L., Grafe S., Hanschmann A. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15;346(1–2):116–20. DOI: 10.1016/j.jns.2014.08.004

20. Маркова Е.Ю., Полунина Е.Г., Иойлева Е.Э. Аллергические заболевания глаз у детей. Современный взгляд на патогенез и лечение. Офтальмология. 2017;14(2):125–129 [Markova E.Y., Polunina E.G., Ioileva E.E. Аllergic eye diseases in children. modern view on pathogenesis and treatment. Ophthalmology in Russia = Oftal’mologiya. 2017;14(2):125–129 (In Russ.)]. DOI: 10.18008/1816-5095-2017-2-125-129

21. Каспарова Е.А., Зайцев А.В., Каспарова Е.А., Каспаров А.А. Микродиатермокоагуляция в лечении инфекционных язв роговицы. Офтальмология. 2016;13(3):157–162 [Kasparova E.A., Zajcev A.V., Kasparova E.A., Kasparov A.A. Мicro diathermocoagulation in the treatment of infectious corneal ulcers. Ophthalmology in Russia = Oftal’mologiya. 2016;13(3):157–162 (In Russ.)]. DOI: 10.18008/1816-5095-2016-3-157-162

22. Ho M.C., Hsu W.C., Hsieh Y.T. Botulinum toxin type a injection for lateral canthal rhytids: effect on tear film stability and tear production. JAMA Ophthalmology. 2014;132(3):332–337.